In addition, it could be pointed out that the inclusion of tumor necrosis factor (TNF)-alpha inhibitor in the therapy protocol for these patients resolved RA disease activity simultaneously with the decline in serologic indicators of active EBV infection. Here, TNF is linked to Epstein-Barr virus infection.